JPRN-UMIN000004590已完成2 期
orth Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer(NORTH/HGCSG1003 study) - North Japan multicenter phase II study of oxaliplatin-containing regimen as adjuvant chemotherapy for stage III colon cancer(NORTH/HGCSG1003 study)
PO Hokkaido Gastrointestinal Cancer Study Group (HGCSG)0 个研究点目标入组 270 人开始时间: 2011年1月15日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Multiple cancer patient 2)Patients who had other cancer within 5 years. 3)Pregnant or lactating women. 4)Patients who had colorectal cancer excluded mucosal cancer. 5)Peripheral sensory neuropathy or Paresthesia(CTCAE v4.0 >= Grade 1). 6)Uncontrolled congestive heart failure or angina pectoris, or hypertension or arrhythmia. 7)History of significant neurologic or psychiatric disorders. 8)Active infection.
研究者
相似试验
进行中（未招募）
1 期
Multicentre phase 2 study of neoadjuvant oxaliplatin and capecitabine followed by chemo-radiotherapy in patients with locally advanced carcinoma of esphago-gastric junction.ocally advanced carcinoma (squamous or adenocarcinoma) of the esophago-gastric junction Siewert type I and IIMedDRA version: 14.1Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 100000004864EUCTR2013-001630-18-ITIstituto Nazionale per lo Studio e la Cura dei Tumori di Napoli – Fondazione G.Pascale”40
招募中
2 期
Phase II Study of Weekly Oxaliplatin With Continous Infusion Fluorouracil And Concurrent Radiation for Treatment of Localised Oesophageal CarcinomaHistologically confirmed localised squamous cell carcinoma of the oesophagusAdenocarcinoma of the oesophagusCancer - Oesophageal (gullet)ACTRN12605000106639Princess Alexandra Hospital30
已完成
3 期
A randomized phase III study of oxaliplatin based chemotherapy versus combination chemotherapy of TS-1,irinotecan and bevacizumab as first line therapy for unresectable or recurrent colorectal cancerJPRN-UMIN000007834The Tokyo Cooperative Oncology Group450
已完成
2 期
Phase II clinical trial on systemic oxaliplatin chemotherapy plus molecular target therapy combined with hepatic arterial infusion (HAI) therapy for colorectal liver metastasesColorectal cancerJPRN-UMIN000019466Department of Gastroenterological Surgery, Tokai University School of Medicine47
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42